Date: 23.7.2021
Summary:
A Spanish biotech company dedicated to developing first-in-class novel Therapeutic Molecular Clusters (TMCs) has a pipeline of molecules with potent anticancer activity by several mechanisms of action and molecules active against bacterial and fungal pathogens protected by patents. TMCs freely diffuse across the blood brain barrier and into avascular structures with low levels of off-target toxicity. The company looks for research cooperation or commercial agreements with technical assistance.
Reference: TOES20210609003
Country: Spain
Submitted: 23. 7. 2021
Keywords
Technology: Cytology, Cancerology, Oncology; Medical Technology / Biomedical Engineering; Pharmaceutical Products / Drugs.
Market: Oncology.
NACE: -
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Animal Biotechnology - Animals, animal biotech
OECD Biotechnology Topic - Organisation for Economic Co-operation and Development
Inhalable sensors could enable early lung cancer detection
Nanotweezers manipulate bacteriophages with minimal optical power, a breakthrough for phage therapy